BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23733246)

  • 21. lncRNA-NEAT1 Sponges miR-128 to Promote Inflammatory Reaction and Phenotypic Transformation of Airway Smooth Muscle Cells.
    Song D; Jiang Y; Zhao Q; Li J; Zhao Y
    Comput Math Methods Med; 2022; 2022():7499911. PubMed ID: 35082915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
    Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
    BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application.
    Aili Y; Maimaitiming N; Mahemuti Y; Qin H; Wang Y; Wang Z
    Front Oncol; 2021; 11():686369. PubMed ID: 34540663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutraceutical regulation of miRNAs involved in neurodegenerative diseases and brain cancers.
    Ghosh S; Kumar V; Mukherjee H; Lahiri D; Roy P
    Heliyon; 2021 Jun; 7(6):e07262. PubMed ID: 34195404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of Long Non-Coding RNA HCP5 Increases Radiosensitivity Through Cellular Senescence by Regulating microRNA-128 in Gliomas.
    Wang C; Yu G; Xu Y; Liu C; Sun Q; Li W; Sun J; Jiang Y; Ye L
    Cancer Manag Res; 2021; 13():3723-3737. PubMed ID: 33994812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Sonic Hedgehog Pathway to Suppress the Expression of the Cancer Stem Cell (CSC)-Related Transcription Factors and CSC-Driven Thyroid Tumor Growth.
    Lu Y; Zhu Y; Deng S; Chen Y; Li W; Sun J; Xu X
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epigenetics of Glioma Stem Cells: A Brief Overview.
    Valor LM; Hervás-Corpión I
    Front Oncol; 2020; 10():602378. PubMed ID: 33344253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of small noncoding RNA for glioblastoma.
    Yoo JY; Yeh M; Kaur B; Lee TJ
    Cancer Lett; 2021 Mar; 500():274-280. PubMed ID: 33176185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of lncRNA PCAT1 Enhances Radiosensitivity of Cervical Cancer by Regulating miR-128/GOLM1 Axis.
    Ge X; Gu Y; Li D; Jiang M; Zhao S; Li Z; Liu S
    Onco Targets Ther; 2020; 13():10373-10385. PubMed ID: 33116617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Molecular Signatures in Neural Differentiation and Neurological Diseases Using Digital Color-Coded Molecular Barcoding.
    Salerno D; Rosa A
    Stem Cells Int; 2020; 2020():8852313. PubMed ID: 33005195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics.
    Sadakierska-Chudy A
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32906681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
    Zhang Y; Liu Y; Liu H; Zhao Z; Wu F; Zeng F
    Front Oncol; 2020; 10():508. PubMed ID: 32373523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.
    DeOcesano-Pereira C; Machado RAC; Chudzinski-Tavassi AM; Sogayar MC
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory networks between Polycomb complexes and non-coding RNAs in the central nervous system.
    Xu YJ; Liu PP; Ng SC; Teng ZQ; Liu CM
    J Mol Cell Biol; 2020 Jun; 12(5):327-336. PubMed ID: 31291646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
    Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
    Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy.
    Ogawa D; Ansari K; Nowicki MO; Salińska E; Bronisz A; Godlewski J
    Noncoding RNA; 2019 Mar; 5(1):. PubMed ID: 30875963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer.
    Godlewski J; Lenart J; Salinska E
    Noncoding RNA; 2019 Feb; 5(1):. PubMed ID: 30813461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.
    Bhaskaran V; Nowicki MO; Idriss M; Jimenez MA; Lugli G; Hayes JL; Mahmoud AB; Zane RE; Passaro C; Ligon KL; Haas-Kogan D; Bronisz A; Godlewski J; Lawler SE; Chiocca EA; Peruzzi P
    Nat Commun; 2019 Jan; 10(1):442. PubMed ID: 30683859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.
    Krichevsky AM; Uhlmann EJ
    Neurotherapeutics; 2019 Apr; 16(2):319-347. PubMed ID: 30644073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular Vesicles as Conduits of Non-Coding RNA Emission and Intercellular Transfer in Brain Tumors.
    Spinelli C; Adnani L; Choi D; Rak J
    Noncoding RNA; 2018 Dec; 5(1):. PubMed ID: 30585246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.